| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/02/1998 | EP0861660A1 Curative medicine for disease caused by infection of Helicobacter |
| 09/02/1998 | EP0861659A1 Sustained release drug delivery devices |
| 09/02/1998 | EP0861595A1 Gymnema inodorum roasted tea and method for preparing the same |
| 09/02/1998 | EP0861329A1 Dodecahedral adenoviral protein complex, composition containing same and uses thereof |
| 09/02/1998 | EP0861322A1 Antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for replication |
| 09/02/1998 | EP0861321A2 Phosphopantetheinyl transferases and uses thereof |
| 09/02/1998 | EP0861319A1 Immunity against actinobacillus pleuropneumoniae's rtx toxins apx |
| 09/02/1998 | EP0861267A1 Inducing resistance to tumor growth with soluble igf-1 receptor |
| 09/02/1998 | EP0861266A1 Peptide conjugates derived from thymic hormones, their use as medicament and compositions containing them |
| 09/02/1998 | EP0861261A1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 09/02/1998 | EP0861260A1 Improved method and agents for inhibiting protein aging |
| 09/02/1998 | EP0861257A1 Spiro piperidine derivatives as 5mt receptor antagonists |
| 09/02/1998 | EP0861256A1 1-azabicycloheptane derivatives and their pharmaceutical use |
| 09/02/1998 | EP0861255A1 Hemoregulatory compounds |
| 09/02/1998 | EP0861254A1 Hemoregulatory compounds |
| 09/02/1998 | EP0861253A1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 09/02/1998 | EP0861252A1 NAPHTHAMIDE DERIVATIVES OF 3 $g(b)-AMINO AZABICYCLO OCTANE OR NONANE AS NEUROLEPTIC AGENTS |
| 09/02/1998 | EP0861251A1 Morpholine derivatives and their use as therapeutic agents |
| 09/02/1998 | EP0861250A1 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase |
| 09/02/1998 | EP0861249A1 Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 09/02/1998 | EP0861248A1 Indolealkyl derivatives of benzodioxanmethylamine as 5-ht1a receptor ligands |
| 09/02/1998 | EP0861247A1 Novel imidazole n-benzyldioxol derivatives, method for preparing same, resulting intermediates, pharmaceutical compositions and use of said derivatives as endothelin antagonists |
| 09/02/1998 | EP0861246A1 Prolylendopeptidase inhibitors |
| 09/02/1998 | EP0861243A1 Heterocyclic compounds as bradykinin antagonists |
| 09/02/1998 | EP0861240A1 Processes and intermediates for preparing 1-(2- 2-isoxazol-3-ylbenzofuran-5-yloxy]ethylamino)-3-phenoxy-2(s)-ol |
| 09/02/1998 | EP0861238A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 09/02/1998 | EP0861236A1 Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids |
| 09/02/1998 | EP0861235A1 Substituted benzylaminopiperidine compounds |
| 09/02/1998 | EP0861234A1 Enantiomers of cis-benz e]indole compounds, their preparation and utility as dopamine-d3 receptor selective agents |
| 09/02/1998 | EP0861231A1 L-n?6 -(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors |
| 09/02/1998 | EP0861228A1 Lipopolyamines as transfection agents and pharmaceutical uses thereof |
| 09/02/1998 | EP0861226A1 Synthesis of carboxylic acid derivatives |
| 09/02/1998 | EP0861091A1 Immunotoxin containing a disulfide-stabilized antibody fragment |
| 09/02/1998 | EP0861090A1 Tumor associated internalizing antigens and methods for targeting therapeutic agents |
| 09/02/1998 | EP0861088A1 Bactericidal permeability increasing protein (bpi) for treating conditions associated with corneal injury |
| 09/02/1998 | EP0861087A1 Bactericidal/permeability increasing protein (bpi) for treating conditions associated with corneal transplantation |
| 09/02/1998 | EP0861085A1 Anti-viral isolates obtainable from leeches |
| 09/02/1998 | EP0861084A1 Improved process and composition for therapeutic cisplatin (cddp) |
| 09/02/1998 | EP0861083A1 Microcellulose-based preparations |
| 09/02/1998 | EP0861082A1 Therapy for tissue membrane insufficiency |
| 09/02/1998 | EP0861081A1 Use of epinastine in the treatment of pain |
| 09/02/1998 | EP0861080A1 Hemoregulatory compounds |
| 09/02/1998 | EP0861079A1 Combination therapy for treating glaucoma |
| 09/02/1998 | EP0861078A1 Hemoregulatory compounds |
| 09/02/1998 | EP0861077A1 Hemoregulatory compounds |
| 09/02/1998 | EP0861076A1 Hemoregulatory compounds |
| 09/02/1998 | EP0861075A1 Analgesic compounds and uses thereof |
| 09/02/1998 | EP0861074A1 Non-ionic surfactant vesicles as therapeutic agent |
| 09/02/1998 | EP0861073A1 Stabilized thyroid hormone preparations and methods of making same |
| 09/02/1998 | EP0861072A2 Compositions for the treatment of blood disorders |
| 09/02/1998 | EP0861071A1 Benzamidoxime prodrugs as antipneumocystic agents |
| 09/02/1998 | EP0861070A2 Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis |
| 09/02/1998 | EP0861068A2 Method and device for producing a parenteral medicament |
| 09/02/1998 | EP0861067A1 Unit galenical form for local hormonotherapy of vaginal dryness |
| 09/02/1998 | EP0861066A1 Improved pseudocatalase composition |
| 09/02/1998 | EP0861054A1 Photochemistry for the preparation of biologic grafts-allografts and xenografts |
| 09/02/1998 | EP0861030A1 Hemoregulatory compounds |
| 09/02/1998 | EP0861029A1 Hemoregulatory compounds |
| 09/02/1998 | EP0861027A1 IceA GENE AND RELATED METHODS |
| 09/02/1998 | EP0783512A4 Novel androstanes for inducing hypothalamic effects |
| 09/02/1998 | EP0732921A4 C-glycoside analogues of n-(4-hydroxyphenyl)retinamide-o-glucuronide |
| 09/02/1998 | EP0703919B1 Phosphosuccinic acid derivatives and their use as medicaments |
| 09/02/1998 | EP0691964B1 (3-ketotetrahydrofuran-2-yl)ethanal derivatives and a method for their preparation |
| 09/02/1998 | EP0686044B1 Inhibition of intimal hyperplasia using antibodies to pdgf receptors |
| 09/02/1998 | EP0682649B1 Deuterated sevoflurane as an inhalational anesthetic |
| 09/02/1998 | EP0674716B1 Retroviral vectors for the treatment of tumors, and cell lines containing them |
| 09/02/1998 | EP0593511B1 Piperidine derivates having anxiolytic effect |
| 09/02/1998 | EP0426785B1 Compositions and methods for treating viral infections |
| 09/02/1998 | EP0413706B1 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents |
| 09/02/1998 | CN1192247A Production of 'beta'-glucan-mannan preparations by autolysis of cells under certain pH, temperature and time conditions |
| 09/02/1998 | CN1192237A 人MP52 Arg蛋白 People MP52 Arg protein |
| 09/02/1998 | CN1192219A Reversible cysteine protease inhibitors |
| 09/02/1998 | CN1192216A Substituted liposaccharides useful in the treatment and prevention of endotoxemia |
| 09/02/1998 | CN1192213A (R)-5-bromo-N-(1-ethyl-4-methylhexahy dro-1H-1,4-diazepin-6-YL)-2-methoxy-6-methylamino-3-pyridine-carboxamide |
| 09/02/1998 | CN1192209A Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas |
| 09/02/1998 | CN1192207A 2-substituted benzimidazole derivatives as inhibitors of smooth muscle cell proliferation |
| 09/02/1998 | CN1192206A Styryl benzimidazole derivatives as inhibitors of smooth muscle cell proliferation |
| 09/02/1998 | CN1192205A Benzimidazole derivatives as inhibitors of smooth muscle cell proliferation |
| 09/02/1998 | CN1192204A 2-substituted benzimidazole derivatives as smooth muscle cell proliferation inhibitors |
| 09/02/1998 | CN1192202A Diheterocyclic acrylonitriles as smooth muscle cell proliferation inhibitors |
| 09/02/1998 | CN1192201A N-(aroyl) glycine hydroxamic acid derivatives and related compounds |
| 09/02/1998 | CN1192199A 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives |
| 09/02/1998 | CN1192158A Method of treatment for asthma |
| 09/02/1998 | CN1192155A Hemodilution facilitated by monitoring oxygenation status |
| 09/02/1998 | CN1192150A Tablets containing anion exchange resin |
| 09/02/1998 | CN1192149A Methods of reducing toxicity of chemotherapeutic and antiviral agents with acylated pyrimidine nucleosides |
| 09/02/1998 | CN1192148A Use of phenol substituted diphosphonates as antineoplastic agents |
| 09/02/1998 | CN1192147A Imidazole compounds |
| 09/02/1998 | CN1192146A 4,4-(disubstituted) cyclohexan-1-ols)-monomers and related compounds |
| 09/02/1998 | CN1192145A Methods for minimizing bone loss |
| 09/02/1998 | CN1192144A 1H-4(5)-substituted imidazole derivatives |
| 09/02/1998 | CN1192142A Use of 1H-1,2,4-triazole derivatives for inhibiting the growth of cancers |
| 09/02/1998 | CN1192141A Methods for inhibiting melanoma |
| 09/02/1998 | CN1192140A Use of sulfamic acid derivatives, acyl sulfonamides or sulfonyl carbamates for the manufacture of a medicament for lowering lipoprotein levels |
| 09/02/1998 | CN1192139A Use of agonists or antagonists of P2 purinoceptors for the prevention of g lutamate-evoked cytotoxicity |
| 09/02/1998 | CN1192138A Acyclovir derivatives for topical use |
| 09/02/1998 | CN1192136A Liquid fluorocarbon emulsion as a vascular nitric oxide reservoir |
| 09/02/1998 | CN1192134A Topical vehicles containing solubilized and stabilized azelaic acid |
| 09/02/1998 | CN1192121A Modulation of calcium channels |
| 09/02/1998 | CN1191898A Self-enhancing, pharmacologically controllable expression systems |